Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 383, Issue 14, Pages 1358-1374Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMra1904794
Keywords
-
Categories
Funding
- Associazione Italiana per la Ricerca sul Cancro (Milan)
Ask authors/readers for more resources
MDS are clonal hematopoietic disorders involving morphologic defects and peripheral-blood cytopenias, with a risk of progression to acute myeloid leukemia. Except for del(5q) MDS, which is responsive to lenalidomide, these disorders are largely managed with supportive care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
